No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

GALEN regimen, Phase 2 trial

byKathleen Lau

December 31, 2021

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

Grading carcinoembryonic antigen levels can enhance prognostic stratification in colorectal cancer

Machine learning algorithm shows limited capacity for reducing health spending for radiation therapy outpatients.

2 Minute Medicine Rewind November 4, 2024

Tags: #cancer advanced follicular lymphoma advanced lymphoma blood blood cancer cancer chemo-free chemotherapy complete response rate CRR efficacy outcomes febrile neutropenia FL follicular lymphoma GALEN hematology high tumor burden high tumour burden induction infection infusion-related reaction IWG 1999 Criteria lenalidomide maintenance neutropenia Obinutuzumab oncology os overall survival pfs previously untreated lymphoma progression-free survival skin reaction survival outcomes untreated lymphoma

Moderate caffeine intake may not be associated with cardiometabolic pregnancy complications

RelatedReports

Development of a risk index for colorectal cancer screening

Chronic Disease

Grading carcinoembryonic antigen levels can enhance prognostic stratification in colorectal cancer

November 7, 2024

Parental debt influences child socioemotional well-being

2 Minute Medicine

Machine learning algorithm shows limited capacity for reducing health spending for radiation therapy outpatients.

November 5, 2024

Provision of medically-tailored meals linked with lower admissions and medical spending

Weekly Rewinds

2 Minute Medicine Rewind November 4, 2024

November 4, 2024

Cervical cancer screening practices less cost-effective than suggested guidelines

Chronic Disease

Induction chemotherapy followed by chemoradiotherapy improves survival in advanced cervical cancer

November 1, 2024

Influenza vaccine not associated with increased risk of epilepsy in children

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

2 Minute Medicine Rewind January 3, 2022

Kangaroo mother care linked to better neonatal outcomes

Mediterranean diet and mindfulness-strategies reduced risk of low-birth-weight newborns

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

GALEN regimen, Phase 2 trial

Grading carcinoembryonic antigen levels can enhance prognostic stratification in colorectal cancer

Machine learning algorithm shows limited capacity for reducing health spending for radiation therapy outpatients.

2 Minute Medicine Rewind November 4, 2024

Moderate caffeine intake may not be associated with cardiometabolic pregnancy complications

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

RelatedReports

Grading carcinoembryonic antigen levels can enhance prognostic stratification in colorectal cancer

Machine learning algorithm shows limited capacity for reducing health spending for radiation therapy outpatients.

2 Minute Medicine Rewind November 4, 2024

Induction chemotherapy followed by chemoradiotherapy improves survival in advanced cervical cancer

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

2 Minute Medicine Rewind January 3, 2022

Mediterranean diet and mindfulness-strategies reduced risk of low-birth-weight newborns

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

GALEN regimen, Phase 2 trial

RELATED REPORTS

Moderate caffeine intake may not be associated with cardiometabolic pregnancy complications

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?